Tranexid 10% injection
Ingredients in every 5 ml
|Tranexamic acid||500 mg|
Each package contains
|ATC Level 1||B - Blood and blood forming organs|
|ATC Level 2||B02 - Antihemorrhagics|
|ATC Level 3||B02A - Antifibrinolytics|
Hereditary angioneurotic edema, 500-1000 mg tranexamic acid by slow intravenous injection (maximum 100 mg/min; 2 ml/min for Tranexid 250 mg/5 ml; 1 ml/min for Tranexid 500 mg/5 ml) 3 times daily. For the treatment more than 3 days, it should be considered to use an oral tranexamic acid.
1 gram 3 times daily, slow intravenous injection, administered for the first 3 days. Therapy is then continued, using 1 gram tranexamic acid orally 3-4 times daily (starts on the fourth day after surgery until macroscopic hematuria is no longer present).
TOOTH EXTRACTION IN PATIENTS WITH HEMOPHILIA
– Immediately before tooth extraction: intravenous, 10 mg/kg of body weight.
– Postsurgical: 25 mg/kg of body weight (orally) 3-4 times daily for 2-8 days.
(for patient unable to take medication orally, intravenous therapy, 10 mg/kg of body weight, 3-4 daily).
PATIENTS WITH RENAL FUNCTION DISORDERS
– Serum creatinine 120-250 micromol/l (1.36-2.83 mg/dl):
IV Dose 10 mg/kg, 2 times daily
– Serum creatinine 250-500 micromol/l (2.83-5.66 mg/dl):
IV Dose 10 mg/kg, once daily
– Serum creatinine >500 micromol/l (>5.66 mg/dl):
IV Dose 10 mg/kg, every 48 hours or 5 mg/kg every 24 hours
– Fibrinolysis in menorrhagia, epistaxis, traumatic hyphema, neoplasma, obstetric complications, and other surgical procedures including bladder surgery, prostatectomy or conization of the cervix.
– Tooth extraction in patients with hemophilia and prophylactic treatment of hereditary angioedema.